Genomic Answers for Children’s Health Act of 2026

HR 7118, the Genomic Answers for Children’s Health Act of 2026, requires Medicaid to cover whole genome and whole exome sequencing for Medicaid-eligible children with specific medical needs, including genetic disorders, rare diseases, congenital anomalies, developmental delays, or intellectual disabilities. It mandates that this testing be ordered as a first-tier test by a physician and paid separately, not bundled with other services. The bill also requires the Department of Health and Human Services to convene stakeholders, conduct outreach to raise awareness, and publish a report within two years detailing state payment rates and usage data. Additionally, it directs a Comptroller General report assessing implementation barriers, workforce challenges, and payment alignment with market costs. The changes take effect January 1, 2027.